Advanced search
Publication Cover
British Journal of Neurosurgery Volume 23, 2009 - Issue 4
Submit an article Journal homepage
929
Views
81
CrossRef citations to date
0
Altmetric
Review Article

The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials

Barry L. Pizer Department of Paediatric Oncology, Alder Hey Children's Hospital, Liverpool, UK
&
Steven C. Clifford Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UKCorrespondence[email protected]
Pages 364-375 | Received 08 Jun 2009, Accepted 16 Jun 2009, Published online: 15 Sep 2009

Citations (81)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Qiang Li, Yanfei Jia, Bo Tang, Hu Yang, Qiang Yang, Xiaodong Luo & Yawen Pan. (2023) Mitochondrial subtype MB-G3 contains potential novel biomarkers and therapeutic targets associated with prognosis of medulloblastoma. Biomarkers 28:7, pages 643-651.
Read now
Jonathan Fisher, Dipayan Mitra, Lisa Price, Joanne Lewis, Hina Johnstone, Amanda Gerrard, Juliet Hale, Steven C. Clifford & Simon Bailey. (2012) The importance of biopsy following radiological diagnosis of relapsed medulloblastoma. British Journal of Neurosurgery 26:4, pages 542-544.
Read now
Cyrus Chargari, Loïc Feuvret, Antonin Levy, Ionnis Lamproglou, Avi Assouline, Charles Hemery, Lilia Ghorbal, Stephane Lopez, Bernadette Tep, Gilbert Boisserie G, Philippe Lang, Florence Laigle-Donadey, Philippe Cornu, Jean-Jacques Mazeron & Jean-Marc Simon. (2010) Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse. British Journal of Neurosurgery 24:4, pages 460-467.
Read now

Articles from other publishers (78)

Sarah Kohe, Christopher Bennett, Florence Burté, Magretta Adiamah, Heather Rose, Lara Worthington, Fatma Scerif, Lesley MacPherson, Simrandip Gill, Debbie Hicks, Edward C. Schwalbe, Stephen Crosier, Lisa Storer, Ambarasu Lourdusamy, Dipyan Mitra, Paul S. Morgan, Robert A. Dineen, Shivaram Avula, Barry Pizer, Martin Wilson, Nigel Davies, Daniel Tennant, Simon Bailey, Daniel Williamson, Theodoros N. Arvanitis, Richard G. Grundy, Steven C. Clifford & Andrew C. Peet. (2024) Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups. eBioMedicine 100, pages 104958.
Crossref
Johid Reza Malik, Anthony T. Podany, Parvez Khan, Christopher L. Shaffer, Jawed A. Siddiqui, Janina Baranowska‐Kortylewicz, Jennifer Le, Courtney V. Fletcher, Sadia Afruz Ether & Sean N. Avedissian. (2023) Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier. Cancer Medicine 12:23, pages 21075-21096.
Crossref
Marco Agostini, Pietro Traldi & Mahmoud Hamdan. (2023) Mass Spectrometry-Based Proteomics: Analyses Related to Drug-Resistance and Disease Biomarkers. Medicina 59:10, pages 1722.
Crossref
Charikleia Ntenti, Konstantinos Lallas & Georgios Papazisis. (2023) Clinical, Histological, and Molecular Prognostic Factors in Childhood Medulloblastoma: Where Do We Stand?. Diagnostics 13:11, pages 1915.
Crossref
Maher Kurdi, Nasser Mulla, Husam Malibary, Ahmed K Bamaga, Motaz M Fadul, Eyad Faizo, Sahar Hakamy & Saleh Baeesa. (2023) Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors. World Journal of Clinical Oncology 14:3, pages 117-130.
Crossref
Livia Fratini, Matheus Gibeke Siqueira Dalmolin, Marialva Sinigaglia, Alexandre da Silveira Perla, Caroline Brunetto de Farias, Algemir L. Brunetto, André T. Brunetto, Mariane da Cunha Jaeger & Rafael Roesler. (2022) ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma. NeuroMolecular Medicine 25:1, pages 64-74.
Crossref
Zhi-ming Liu, Heng Zhang, Ming Ge, Xiao-lei Hao, Xu An & Yong-ji Tian. (2022) Radiomics signature for the prediction of progression-free survival and radiotherapeutic benefits in pediatric medulloblastoma. Child's Nervous System 38:6, pages 1085-1094.
Crossref
Mike-Andrew Westhoff, Marie Schuler-Ortoli, Daniela Zerrinius, Amina Hadzalic, Andrea Schuster, Hannah Strobel, Angelika Scheuerle, Tiana Wong, Christian Rainer Wirtz, Klaus-Michael Debatin & Aurelia Peraud. (2022) Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy. Pharmaceuticals 15:1, pages 91.
Crossref
Stacey Richardson, Rebecca M Hill, Christopher Kui, Janet C Lindsey, Yura Grabovksa, Claire Keeling, Louise Pease, Matthew Bashton, Stephen Crosier, Maria Vinci, Nicolas André, Dominique Figarella-Branger, Jordan R Hansford, Maria Lastowska, Krzysztof Zakrzewski, Mette Jorgensen, Jessica C Pickles, Michael D Taylor, Stefan M Pfister, Stephen B Wharton, Barry Pizer, Antony Michalski, Abhijit Joshi, Thomas S Jacques, Debbie Hicks, Edward C Schwalbe, Daniel Williamson, Vijay Ramaswamy, Simon Bailey & Steven C Clifford. (2022) Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse. Neuro-Oncology 24:1, pages 153-165.
Crossref
Colin Thorbinson & John-Paul Kilday. (2021) Childhood Malignant Brain Tumors: Balancing the Bench and Bedside. Cancers 13:23, pages 6099.
Crossref
Mingui Zhang, Tao Chen & Yisheng Zhong. (2021) Demographic and prognostic factors of optic nerve astrocytoma: a retrospective study of surveillance, epidemiology, and end results (SEER). BMC Cancer 21:1.
Crossref
Marina Danilenko, Steven C. Clifford & Edward C. Schwalbe. (2021) Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma. Pharmacology & Therapeutics 228, pages 107828.
Crossref
Sophie J. Roper, Franziska Linke, Paul J. Scotting & Beth Coyle. (2021) 3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination. Scientific Reports 11:1.
Crossref
D. Hicks, G. Rafiee, E. C. Schwalbe, C. I. Howell, J. C. Lindsey, R. M. Hill, A. J. Smith, P. Adidharma, C. Steel, S. Richardson, L. Pease, M. Danilenko, S. Crosier, A. Joshi, S. B. Wharton, T. S. Jacques, B. Pizer, A. Michalski, D. Williamson, S. Bailey & S. C. Clifford. (2020) The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second‐generation subtypes. Neuropathology and Applied Neurobiology 47:2, pages 236-250.
Crossref
A. Rolland & K. Aquilina. (2021) Surgery for recurrent medulloblastoma: A review. Neurochirurgie 67:1, pages 69-75.
Crossref
Christian Carrie, Virginie Kieffer, Dominique Figarella-Branger, Julien Masliah-Planchon, Stéphanie Bolle, Valérie Bernier, Anne Laprie, Stéphane Supiot, Julie Leseur, Jean-Louis Habrand, Claire Alapetite, Christine Kerr, Christelle Dufour, Line Claude, Sophie Chapet, Aymeri Huchet, Pierre-Yves Bondiau, Alexandre Escande, Gilles Truc, Tan Dat Nguyen, Caroline Pasteuris, Céline Vigneron, Xavier Muracciole, Franck Bourdeaut, Romain Appay, Bernard Dubray, Carole Colin, Céline Ferlay, Sophie Dussart, Sylvie Chabaud & Laetitia Padovani. (2020) Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups. International Journal of Radiation Oncology*Biology*Physics 108:5, pages 1204-1217.
Crossref
Luca Szalontay & Yasmin Khakoo. (2020) Medulloblastoma: an Old Diagnosis with New Promises. Current Oncology Reports 22:9.
Crossref
Anqi Xiong, Ananya Roy, Argyris Spyrou, Holger Weishaupt, Voichita D. Marinescu, Tommie Olofsson, Ola Hermanson, Fredrik J. Swartling & Karin Forsberg-Nilsson. (2020) Nuclear Receptor Binding Protein 2 Is Downregulated in Medulloblastoma, and Reduces Tumor Cell Survival upon Overexpression. Cancers 12:6, pages 1483.
Crossref
Otília Menyhárt & Balázs Győrffy. (2020) Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches. Cancer and Metastasis Reviews 39:1, pages 211-233.
Crossref
Otília Menyhárt, Felice Giangaspero & Balázs Győrffy. (2019) Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas. Journal of Hematology & Oncology 12:1.
Crossref
Tanvi Sharma, Edward C. Schwalbe, Daniel Williamson, Martin Sill, Volker Hovestadt, Martin Mynarek, Stefan Rutkowski, Giles W. Robinson, Amar Gajjar, Florence Cavalli, Vijay Ramaswamy, Michael D. Taylor, Janet C. Lindsey, Rebecca M. Hill, Natalie Jäger, Andrey Korshunov, Debbie Hicks, Simon Bailey, Marcel Kool, Lukas Chavez, Paul A. Northcott, Stefan M. Pfister & Steven C. Clifford. (2019) Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathologica 138:2, pages 309-326.
Crossref
Otília Menyhárt & Balázs Győrffy. (2019) Principles of tumorigenesis and emerging molecular drivers of SHH ‐activated medulloblastomas . Annals of Clinical and Translational Neurology 6:5, pages 990-1005.
Crossref
A. N. Chernov. (2019) The impact of the nerve growth factor on the number of MYCC, MYCN oncogene copies in human medulloblastoma cells. Malignant tumours 9:1, pages 22-28.
Crossref
Guilherme de Souza e Cassia, César Augusto Pinheiro Ferreira Alves, Ajay Taranath, Nicolás Sgarbi López, Ozgur Oztekin, Fabrício Guimarães Gonçalves & Zoltan Patay. (2018) Childhood Medulloblastoma Revisited. Topics in Magnetic Resonance Imaging 27:6, pages 479-502.
Crossref
Tobias Goschzik, Edward C Schwalbe, Debbie Hicks, Amanda Smith, Anja zur Muehlen, Dominique Figarella-Branger, François Doz, Stefan Rutkowski, Birgitta Lannering, Torsten Pietsch & Steven C Clifford. (2018) Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. The Lancet Oncology 19:12, pages 1602-1616.
Crossref
Nourhan Abdelfattah, Subapriya Rajamanickam, Subbarayalu Panneerdoss, Santosh Timilsina, Pooja Yadav, Benjamin C. Onyeagucha, Michael Garcia, Ratna Vadlamudi, Yidong Chen, Andrew Brenner, Peter Houghton & Manjeet K. Rao. (2018) MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma. Nature Communications 9:1.
Crossref
Alexander Hegarty & Yulia Furlong. 2018. Brain Tumors - An Update. Brain Tumors - An Update.
Stefan Rutkowski, Piergiorgio Modena, Daniel Williamson, Kornelius Kerl, Karsten Nysom, Barry Pizer, Ute Bartels, Stephanie Puget, François Doz, Antony Michalski, Katja von Hoff, Mathilde Chevignard, Shivaram Avula, Matthew J Murray, Stefan Schönberger, Thomas Czech, Antoinette Y N Schouten-van Meeteren, Uwe Kordes, Christof M Kramm, Dannis G van Vuurden, Esther Hulleman, Geert O Janssens, Guirish A Solanki, Marie-Luise C van Veelen, Ulrich Thomale, Martin U Schuhmann, Chris Jones, Felice Giangaspero, Dominique Figarella-Branger, Torsten Pietsch, Steve C Clifford, Stefan M Pfister & Stefaan W Van Gool. (2018) Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group. The Lancet Oncology 19:8, pages e419-e428.
Crossref
Shu‐Mei Chen, Tzu‐Kang Lin, Yuan‐Yun Tseng, Chiao‐Hui Tu, Tai‐Ngar Lui, Shiang‐Fu Huang, Ling‐Ling Hsieh & Ying‐Ying Li. (2018) Targeting inhibitors of apoptosis proteins suppresses medulloblastoma cell proliferation via G2/M phase arrest and attenuated neddylation of p21. Cancer Medicine 7:8, pages 3988-4003.
Crossref
J. C. Pickles, C. Hawkins, T. Pietsch & T. S. Jacques. (2018) CNS embryonal tumours: WHO 2016 and beyond . Neuropathology and Applied Neurobiology 44:2, pages 151-162.
Crossref
Nicholas G. Gottardo & Christopher I. Howell. 2018. Brain Tumors in Children. Brain Tumors in Children 131 175 .
Vinod Kumar, Virender Kumar, Timothy McGuire, Donald W. Coulter, John G. Sharp & Ram I. Mahato. (2017) Challenges and Recent Advances in Medulloblastoma Therapy. Trends in Pharmacological Sciences 38:12, pages 1061-1084.
Crossref
Ali G. Saad, Vladimir Balik, Aatif Parvez & Siraj M. El Jamal. (2017) Multifocal Supra and Infratentorial Medulloblastoma in an Adult: Histologic, Immunohistochemical, and Molecular Evaluation of a Rare Case and Review of the Literature. Applied Immunohistochemistry & Molecular Morphology 25:10, pages e89-e94.
Crossref
Elwira Szychot, Kiran Seunarine, Kshitij Mankad, Steffi Thust, Chris Clark, Mark N. Gaze & Antony Michalski. (2017) Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high‐dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour. Pediatric Blood & Cancer 64:11.
Crossref
E. C. Schwalbe, D. Hicks, G. Rafiee, M. Bashton, H. Gohlke, A. Enshaei, S. Potluri, J. Matthiesen, M. Mather, P. Taleongpong, R. Chaston, A. Silmon, A. Curtis, J. C. Lindsey, S. Crosier, A. J. Smith, T. Goschzik, F. Doz, S. Rutkowski, B. Lannering, T. Pietsch, S. Bailey, D. Williamson & S. C. Clifford. (2017) Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures. Scientific Reports 7:1.
Crossref
Kay Ka-Wai Li, Yan Qi, Tian Xia, Aden Ka-Yin Chan, Zhen-Yu Zhang, Abudumijiti Aibaidula, Rong Zhang, Liangfu Zhou, Yu Yao & Ho-Keung Ng. (2017) The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis. Laboratory Investigation 97:8, pages 946-961.
Crossref
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M Hill, Alice Iliasova, Thomas Stone, Barry Pizer, Antony Michalski, Abhijit Joshi, Stephen B Wharton, Thomas S Jacques, Simon Bailey, Daniel Williamson & Steven C Clifford. (2017) Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. The Lancet Oncology 18:7, pages 958-971.
Crossref
Petr Chlapek, Karel Zitterbart, Leos Kren, Lenka Filipova, Jaroslav Sterba & Renata Veselska. (2017) Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups. PLOS ONE 12:2, pages e0172552.
Crossref
Lara A. Brandão & Tina Young Poussaint. (2017) Posterior Fossa Tumors. Neuroimaging Clinics of North America 27:1, pages 1-37.
Crossref
Sebastian Dietl, Stefanie Schwinn, Susanne Dietl, Simone Riedel, Frank Deinlein, Stefan Rutkowski, Andre O. von Bueren, Jürgen Krauss, Tilmann Schweitzer, Giles H. Vince, Daniel Picard, Matthias Eyrich, Andreas Rosenwald, Vijay Ramaswamy, Michael D. Taylor, Marc Remke, Camelia M. Monoranu, Andreas Beilhack, Paul G. Schlegel & Matthias Wölfl. (2016) MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties. BMC Cancer 16:1.
Crossref
Christopher J. Matheson, Sujatha Venkataraman, Vladimir Amani, Peter S. Harris, Donald S. Backos, Andrew M. Donson, Michael F. Wempe, Nicholas K. Foreman, Rajeev Vibhakar & Philip Reigan. (2016) A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells. ACS Chemical Biology 11:4, pages 921-930.
Crossref
Steven C. Clifford, Birgitta Lannering, Ed C. Schwalbe, Debbie Hicks, Kieran O' Toole, Sarah Leigh Nicholson, Tobias Goschzik, Anja zur Mühlen, Dominique Figarella-Branger, François Doz, Stefan Rutkowski, Göran Gustafsson & Torsten Pietsch. (2015) Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial. Oncotarget 6:36, pages 38827-38839.
Crossref
Beth CoyleMaya KesslerDurgagauri H. SabnisIan D. Kerr. (2015) ABCB1 in children's brain tumours. Biochemical Society Transactions 43:5, pages 1018-1022.
Crossref
J C Lindsey, D Kawauchi, E C Schwalbe, D J Solecki, M P Selby, P J McKinnon, J M Olson, J T Hayden, R G Grundy, D W Ellison, D Williamson, S Bailey, M F Roussel & S C Clifford. (2014) Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance. Oncogene 34:36, pages 4746-4757.
Crossref
Fengfei Wang, Marc Remke, Kruttika Bhat, Eric T. Wong, Shuang Zhou, Vijay Ramaswamy, Adrian Dubuc, Ekokobe Fonkem, Saeed Salem, Hongbing Zhang, Tze-chen Hsieh, Stephen T. O’Rourke, Lizi Wu, David W. Li, Cynthia Hawkins, Isaac S. Kohane, Joseph M. Wu, Min Wu, Michael D. Taylor & Erxi Wu. (2014) A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma. Oncotarget 6:5, pages 2709-2724.
Crossref
Rebecca M. Hill, Sanne Kuijper, Janet C. Lindsey, Kevin Petrie, Ed C. Schwalbe, Karen Barker, Jessica K.R. Boult, Daniel Williamson, Zai Ahmad, Albert Hallsworth, Sarra L. Ryan, Evon Poon, Simon P. Robinson, Ruth Ruddle, Florence I. Raynaud, Louise Howell, Colin Kwok, Abhijit Joshi, Sarah Leigh Nicholson, Stephen Crosier, David W. Ellison, Stephen B. Wharton, Keith Robson, Antony Michalski, Darren Hargrave, Thomas S. Jacques, Barry Pizer, Simon Bailey, Fredrik J. Swartling, William A. Weiss, Louis Chesler & Steven C. Clifford. (2015) Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease. Cancer Cell 27:1, pages 72-84.
Crossref
Ramadhan T Othman, Ioanna Kimishi, Tracey D Bradshaw, Lisa CD Storer, Andrey Korshunov, Stefan M Pfister, Richard G Grundy, Ian D Kerr & Beth Coyle. (2014) Overcoming multiple drug resistance mechanisms in medulloblastoma. Acta Neuropathologica Communications 2:1.
Crossref
Allison M. Martin, Eric Raabe, Charles Eberhart & Kenneth J. Cohen. (2014) Management of Pediatric and Adult Patients with Medulloblastoma. Current Treatment Options in Oncology 15:4, pages 581-594.
Crossref
Ruth-Mary DeSouza, Benjamin R. T. Jones, Stephen P. Lowis & Kathreena M. Kurian. (2014) Pediatric Medulloblastoma – Update on Molecular Classification Driving Targeted Therapies. Frontiers in Oncology 4.
Crossref
N.J. Thorp & R.E. Taylor. (2014) Management of Central Nervous System Tumours in Children. Clinical Oncology 26:7, pages 438-445.
Crossref
Maria Łastowska, Hani Al-Afghani, Haya H Al-Balool, Harsh Sheth, Emma Mercer, Jonathan M Coxhead, Chris PF Redfern, Heiko Peters, Alastair D Burt, Mauro Santibanez-Koref, Chris M Bacon, Louis Chesler, Alistair G Rust, David J Adams, Daniel Williamson, Steven C Clifford & Michael S Jackson. (2013) Identification of a neuronal transcription factor network involved in medulloblastoma development. Acta Neuropathologica Communications 1:1.
Crossref
H A Rogers, J H Ward, S Miller, J Lowe, B Coyle & R G Grundy. (2013) The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs). British Journal of Cancer 108:10, pages 2130-2141.
Crossref
David T. W. Jones, Paul A. Northcott, Marcel Kool & Stefan M. Pfister. (2013) The Role of Chromatin Remodeling in Medulloblastoma. Brain Pathology 23:2, pages 193-199.
Crossref
Edward C. Schwalbe, Daniel Williamson, Janet C. Lindsey, Dolores Hamilton, Sarra L. Ryan, Hisham Megahed, Mikl?s Garami, Peter Hauser, Bo?ena Dembowska-Baginska, Danuta Perek, Paul A. Northcott, Michael D. Taylor, Roger E. Taylor, David W. Ellison, Simon Bailey & Steven C. Clifford. (2013) DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathologica 125:3, pages 359-371.
Crossref
Susan L. Whiteway, Peter S. Harris, Sujatha Venkataraman, Irina Alimova, Diane K. Birks, Andrew M. Donson, Nicholas K. Foreman & Rajeev Vibhakar. (2012) Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells. Journal of Neuro-Oncology 111:2, pages 113-121.
Crossref
Raimundo M. Carvalho, Giovanny R. Pinto, France K. N. Yoshioka, Patrícia D. L. Lima, Carolina R. T. Souza, Adriana C. Guimarães, Letícia M. Lamarão, Juan A. Rey & Rommel R. Burbano. (2012) Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients. Journal of Neuro-Oncology 110:1, pages 49-57.
Crossref
Sarra L. Ryan, Ed C. Schwalbe, Michael Cole, Yuan Lu, Meryl E. Lusher, Hisham Megahed, Kieran O’Toole, Sarah Leigh Nicholson, Laszlo Bognar, Miklos Garami, Peter Hauser, Andrey Korshunov, Stefan M. Pfister, Daniel Williamson, Roger E. Taylor, David W. Ellison, Simon Bailey & Steven C. Clifford. (2011) MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathologica 123:4, pages 501-513.
Crossref
Jasmine Lau, Christin Schmidt, Shirley L. Markant, Michael D. Taylor, Robert J. Wechsler-Reya & William A. Weiss. (2012) Matching mice to malignancy: molecular subgroups and models of medulloblastoma. Child's Nervous System 28:4, pages 521-532.
Crossref
Tejpal Gupta, Vimoj Nair, Reena Phurailatpam, Rakesh Jalali & Rajiv Sarin. (2012) Hyperfractionated craniospinal re-irradiation for recurrent/progressive disseminated medulloblastoma using image-guided radiotherapy: leveraging radiobiology with technology. Journal of Radiation Oncology 1:1, pages 87-92.
Crossref
A. K. Park, S.-J. Lee, J. H. Phi, K.-C. Wang, D. G. Kim, B.-K. Cho, C. Haberler, S. Fattet, C. Dufour, S. Puget, C. Sainte-Rose, F. Bourdeaut, J. Grill, O. Delattre, S.-K. Kim & W.-Y. Park. (2011) Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation. Neuro-Oncology 14:2, pages 203-214.
Crossref
Steven C. Clifford. (2012) Evolution after tumour spread. Nature 482:7386, pages 481-482.
Crossref
Rebecca Schüle, Christine Dictus, Benito Campos, Feng Wan, Jörg Felsberg, Rezvan Ahmadi, Franz-Simon Centner, Niels Grabe, Guido Reifenberger, Justo L. Bermejo, Andreas Unterberg & Christel Herold-Mende. (2012) Potential Canonical Wnt Pathway Activation in High-Grade Astrocytomas . The Scientific World Journal 2012, pages 1-11.
Crossref
Ettore Salsano, Rosina Paterra, Miriam Figus, Francesca Menghi, Emanuela Maderna, Bianca Pollo, Carlo Lazzaro Solero, Luca Massimi & Gaetano Finocchiaro. (2011) Expression profile of frizzled receptors in human medulloblastomas. Journal of Neuro-Oncology 106:2, pages 271-280.
Crossref
Jasmine Lau & William A. Weiss. 2013. Animal Models of Brain Tumors. Animal Models of Brain Tumors 83 140 .
Andrea Poretti, Avner Meoded & Thierry A.G.M. Huisman. (2011) Neuroimaging of pediatric posterior fossa tumors including review of the literature. Journal of Magnetic Resonance Imaging 35:1, pages 32-47.
Crossref
Marc RemkeThomas HielscherAndrey KorshunovPaul A. NorthcottSebastian BenderMarcel KoolFrank WestermannAxel BennerHuriye CinMarina RyzhovaDominik SturmHendrik WittDaniel HaagGrischa ToedtAndrea WittmannAnna SchöttlerAndré O. von BuerenAndreas von DeimlingStefan RutkowskiWolfram ScheurlenAndreas E. KulozikMichael D. TaylorPeter LichterStefan M. Pfister. (2011) FSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma . Journal of Clinical Oncology 29:29, pages 3852-3861.
Crossref
Janet C. Lindsey, Rebecca M. Hill, Hisham Megahed, Meryl E. Lusher, Ed C. Schwalbe, Michael Cole, Twala L. Hogg, Richard J. Gilbertson, David W. Ellison, Simon Bailey & Steven C. Clifford. (2011) TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas . Journal of Clinical Oncology 29:12, pages e344-e346.
Crossref
David W. EllisonMehmet KocakJames DaltonHisham MegahedMeryl E. LusherSarra L. RyanWei ZhaoSarah Leigh NicholsonRoger E. TaylorSimon BaileySteven C. Clifford. (2011) Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables. Journal of Clinical Oncology 29:11, pages 1400-1407.
Crossref
Ed C. Schwalbe, Janet C. Lindsey, Debbie Straughton, Twala L. Hogg, Michael Cole, Hisham Megahed, Sarra L. Ryan, Meryl E. Lusher, Michael D. Taylor, Richard J. Gilbertson, David W. Ellison, Simon Bailey & Steven C. Clifford. (2011) Rapid Diagnosis of Medulloblastoma Molecular Subgroups. Clinical Cancer Research 17:7, pages 1883-1894.
Crossref
Karel Zitterbart, Hana Filkova, Lenka Tomasikova, Eva Necesalova, Iva Zambo, Dagmar Kantorova, Iva Slamova, Vladimira Vranova, Dita Zezulkova, Martina Pesakova, Zdenek Pavelka, Renata Veselska, Petr Kuglik & Jaroslav Sterba. (2010) Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma. Journal of Neuro-Oncology 102:1, pages 25-33.
Crossref
David W. Ellison, James Dalton, Mehmet Kocak, Sarah Leigh Nicholson, Charles Fraga, Geoff Neale, Anna M. Kenney, Dan J. Brat, Arie Perry, William H. Yong, Roger E. Taylor, Simon Bailey, Steven C. Clifford & Richard J. Gilbertson. (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathologica 121:3, pages 381-396.
Crossref
Martine F. Roussel & Mary E. Hatten. 2011. Cancer and Development. Cancer and Development 235 282 .
Kristiina Nordfors, Joonas Haapasalo, Miikka Korja, Anssi Niemelä, Jukka Laine, Anna-Kaisa Parkkila, Silvia Pastorekova, Jaromir Pastorek, Abdul Waheed, William S Sly, Seppo Parkkila & Hannu Haapasalo. (2010) The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. BMC Cancer 10:1.
Crossref
R A Daniel, A L Rozanska, E A Mulligan, Y Drew, H D Thomas, D J Castelbuono, Z Hostomsky, E R Plummer, D A Tweddle, A V Boddy, S C Clifford & N J Curtin. (2010) Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699. British Journal of Cancer 103:10, pages 1588-1596.
Crossref
Christopher Traenka, Marc Remke, Andrey Korshunov, Sebastian Bender, Thomas Hielscher, Paul A. Northcott, Hendrik Witt, Marina Ryzhova, Jörg Felsberg, Axel Benner, Stephanie Riester, Wolfram Scheurlen, Thomas G.P. Grunewald, Andreas von Deimling, Andreas E. Kulozik, Guido Reifenberger, Michael D. Taylor, Peter Lichter, Elke Butt & Stefan M. Pfister. (2010) Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma. Cancer Research 70:20, pages 8003-8014.
Crossref
Marta Nekulová, Karel Zitterbart, Jaroslav Štěrba & Renata Veselská. (2010) Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and ∆Np73 in medulloblastoma cell lines. Journal of Molecular Histology 41:4-5, pages 267-275.
Crossref
David W. Ellison. (2010) Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathologica 120:3, pages 305-316.
Crossref
Aurora Navajas & Jordi Giralt. (2010) Evidence in medulloblastomas. Clinical and Translational Oncology 12:4, pages 271-277.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.